Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Anna V. Christophoridou"'
Autor:
Anastasios Karadimitris, Anna V. Christophoridou, Dimitrios Margaritis, Ioannis Kotsianidis, Athanasios Anastasiades, Christina Tsigalou, Irene Bouchliou, Costas Tsatalas, Georgios Bourikas, E. Spanoudakis, Evangelia Nakou
Publikováno v:
Leukemia. 23:510-518
CD4(+)CD25(+)FOXP3(+) T regulatory cells (T(regs)) prevent autoimmunity by restricting overexuberant immune responses, but the same subpopulation can incur detrimental effects on antitumor responses. In both cases, the suppressor potential of T(regs)
Autor:
Freda Passam, Michael G. Alexandrakis, Elias Castanas, Aria Hatzivasili, Andreas Foudoulakis, Anna V. Christophoridou, Despina Kyriakou, Kostas Perisinakis
Publikováno v:
American Journal of Hematology. 75:101-106
Interleukin-16 (IL-16) is a chemoattractant of CD4+ lymphocytes, and it has been implicated in the pathogenesis of various inflammatory diseases. There is evidence that it may have a role in multiple myeloma (MM). In the present study, we determined
Autor:
Ioanna A. Moschandrea, Despina Kyriakou, Freda Passam, Constantina A. Pappa, Anna V. Christophoridou, S Coulocheri, Michael G. Alexandrakis
Publikováno v:
American Journal of Clinical Oncology. 26:135-140
Essential thrombocytosis (ET) is a myeloproliferative disorder resulting in an increased production of abnormal platelets. Reactive thrombocytosis (RT) is occasionally observed in clinical situations including chronic inflammation and malignancy. The
Autor:
Freda Passam, Niki Malliaraki, Nikolaos Karkavitsas, Anna V. Christophoridou, D.S. Kyriakou, Michael G. Alexandrakis
Publikováno v:
Clinical & Laboratory Haematology. 24:155-159
Summary Technetium 99m-2-methoxyisobutil-isonitrile (Tc-99m-MIBI), also called sestaMIBI,has been used successfully to detect malignant tumours at diagnosis. Recently, it hasbeen proposed as a safe and effective tracer in patients with multiple myelo
Autor:
Anna V. Christophoridou, Konstantinos Konstantopoulos, E. Terpos, Meletios A. Dimopoulos, Zafiris Kartasis, M Spyroupoulou-Vlachou, Anastasia Pouli, Eleftheria Hatzimichael, Sossana Delimpasi, Amalia Vassou, Ekaterini Stefanoudaki, Panagiotis Repousis, Anastasia Sioni, Catherine Megalakaki, Stavroula Giannouli, Argiris Symeonidis, Evridiki Michalis, M.-C. Kyrtsonis, Efstathios Kastritis, Flora Zagouri, Maria Roussou, Eirini Katodritou, Michalis Michael
Publikováno v:
Leukemia. 28(10)
Suppression of uninvolved immunoglobulins is common in multiple myeloma (MM) but the prognostic significance of this phenomenon has not been assessed. We evaluated the prognostic significance of the preservation of uninvolved immunoglobulins in 1755
Autor:
Anna V. Christophoridou, Athanasios Anastasiades, Evangelia Nakou, Aggelos Goutzouvelidis, Costas Tsatalas, Emmanouil Spanoudakis, Irene Bouchliou, George Bourikas, Ioannis Kotsianidis, Dimitrios Margaritis
Publikováno v:
American Journal of Hematology.
Autor:
Aloizos G, D.S. Kyriakou, Freda Passam, Boula A, Anna V. Christophoridou, Paraskevi Roussou, Michael G. Alexandrakis
Publikováno v:
Annals of hematology. 82(1)
Angiogenesis plays an important role in multiple myeloma (MM) progression. Various mitogens such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) have been implicated in the angiogenic process of various maligna
Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activity.
Autor:
Michael G. Alexandrakis, Freda H. Passam, Despina S. Kyriakou, Anna V. Christophoridou, Kostas Perisinakis, Aria Hatzivasili, Andreas Foudoulakis, Elias Castanas
Publikováno v:
American Journal of Hematology; Feb2004, Vol. 75 Issue 2, p101-106, 6p
Autor:
Michael G. Alexandrakis, Freda H. Passam, Ioanna A. Moschandrea, Anna V. Christophoridou, Constantina A. Pappa, Stavroula A. Coulocheri, Despina S. Kyriakou
Publikováno v:
American Journal of Clinical Oncology; Apr2003, Vol. 26 Issue 2, p135-140, 6p